Thursday, August 18, 2005 • Vol 11, Issue 16
Drs. Rainer Storb (left) and Mohamed Sorror modified the Charlson Comorbidity Index (CCI) — a scale used to evaluate chronic health issues — into a tool that allows clinicians to more accurately access risks and determine the best treatment for potential blood stem-cell transplant patients.
Photo by Todd McNaught
|
Science Articles
-
A better measure of risks
New questionnaire evaluates health issues secondary to cancer to help researchers better match patients with treatment and predict outcome
-
More WHI answers than meet the eye
PHS paper brings together existing data to illuminate reasons WHI clinical-trial results differ from earlier observational studies
-
Junkyard genius
Basic Sciences researchers find unexpected evolution in a heterochromatin protein's control of mobile genetic elements
General Articles
Briefs
Credits
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2008 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy
Policy.